Description

Ethaverine Hydrochloride is a pharmaceutical-grade active pharmaceutical ingredient (API) primarily recognized for its potent spasmolytic and vasodilatory properties. This compound is critical for the formulation of medications designed to treat smooth muscle spasms, particularly in the cardiovascular and gastrointestinal systems. It is essential for pharmaceutical manufacturers and research institutions developing treatments for conditions such as angina pectoris, peripheral vascular disease, and various visceral spasms. Our supply ensures high purity and consistent quality for reliable integration into your production processes.

Application

• Pharmaceutical API: Primary active ingredient in prescription medications for vasodilation and smooth muscle relaxation.
• Cardiovascular Therapeutics: Formulation of drugs for managing angina pectoris and improving peripheral blood circulation.
• Gastrointestinal Antispasmodics: Used in treatments for irritable bowel syndrome (IBS) and other conditions involving intestinal or biliary tract spasms.
• Veterinary Medicine: Application in veterinary pharmaceuticals for treating spasmodic conditions in animals.
• Biochemical Research: Serves as a reference standard and a key compound in pharmacological studies and drug discovery programs.
• Controlled-Release Formulations: Development of extended-release tablet or capsule formulations to provide prolonged therapeutic effect.

Basic Information

Product Name	Ethaverine Hydrochloride
CAS No.	985-13-7
Molecular Formula	C₂₅H₃₅NO₄·HCl
Molecular Weight	433.01 g/mol
Synonyms	Ethylpapaverine Hydrochloride; Ethaverini Hydrochloridum; Etaverine HCl; 6,7-Diethoxy-1-(3,4-diethoxybenzyl)isoquinoline Hydrochloride; NSC 126771; 1-(3,4-Diethoxybenzyl)-6,7-diethoxyisoquinoline Hydrochloride; Papaverine Ethyl Ether Hydrochloride; Ethyl Papaverine Hydrochloride
EINECS	213-580-5

Quality Control

Our Ethaverine Hydrochloride is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing to ensure it meets stringent specifications for identity, purity, and potency, suitable for pharmaceutical applications. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting compliance with relevant internal and industry standards. We support our clients' regulatory needs with full traceability and documentation.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed to protect from moisture. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White or almost white, crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time corresponds to reference standard
Assay (HPLC)	98.5% - 101.5% (on anhydrous basis)
Water (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm
Related Substances (HPLC)	Total impurities ≤ 1.0% Any single impurity ≤ 0.5%
Microbial Limits	Conforms to EP/JP requirements

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.